AQUADETRIM TOPS THE RUSSIAN VITAMIN MARKET

16.03.2021

Aquadetrim brand by Akrikhin has topped the Russian purchased vitamin market.

Aquadetrim is a vitamin D preparation, the flagship and the prominent leader of the vitamin D category, and according to the results of the past 12 months, it has topped Russian vitamin market in sales value, that is 2.7 billion rubles1.

The demand for vitamin D is due to the results of numerous scientific studies proving its significant role in human health. Vitamin D regulates the processes of calcium and phosphorus absorption and metabolism, it helps to regulate carbohydrate and lipid metabolism. Vitamin D has been observed to take part in reducing the risk of frequent colds. At the same time, the results of Akrikhin in-house 2020 research2, revealed a widespread problem of vitamin D deficiency and insufficiency in the majority of population, regardless of their place of living. Thus, 84% of Russians suffer from vitamin D deficiency or insufficiency. To maintain optimal vitamin D levels, an adult needs a daily intake of at least 1,500-2,000 IU.

Aquadetrim has long been the absolute leader in the vitamin D market and a key driver of its growth. And now, the brand has topped the list of all purchased vitamins in the country. Vitamin D levels have been scientifically proven to be important for immunity, metabolism, nervous, muscular, bone, and cardiovascular systems. Akrikhin has a broad expertise in this field, and our own research demonstrates the high urgency of the problem of vitamin D deficiency among Russians. We strive to contribute to its solution and implement educational projects in this area. Therefore, such a result is very significant for our company,

– says Alexey Maltsev, Vice President for OTC Sales and Marketing at Akrikhin.


1According to the IQVIA Solutions database "Retail audit of Registration Service in Russia" for pharmaceuticals sales in wholesale ruble prices in 12 months from February 2020 through January 2021.

2Based on the results of epidemiological study conducted by AKRIKHIN at the Invitro laboratories among Russian adults (1st stage: March-June 2020), https://d-ficitu.net/about/.


We use cookies to improve your experience on our site and to show you personalised advertising. By pressing “I AGREE” you accept our cookies policy.
To find out more, go to cookies policy.
I AGREE